Histidine-Tryptophane-Ketoglutarate (HTK) vs University of Wisconsin (UW) Perfusion in Clinical Pancreas Transplantation

PHASE4CompletedINTERVENTIONAL
Enrollment

68

Participants

Timeline

Start Date

July 31, 2001

Primary Completion Date

January 31, 2004

Study Completion Date

December 31, 2005

Conditions
Diabetes MellitusPancreas Transplantation
Interventions
OTHER

Organ perfusion during pancreas procurement

Usage of UW or HTK perfusion solution during in situ abdominal organ perfusion in multi-organ procurement

Trial Locations (4)

6020

Center of Operative Medicine / Department of Visceral, Transplant and Thoracic Surgery / Medical University Innsbruck, Innsbruck

9000

Department of General, Hepato-Biliary and Transplantation Surgery, Ghent

13353

Department of General, Visceral and Transplantation Surgery, Charite Campus Virchow Klinikum, Humboldt University Berlin, Berlin

18057

Department of General, Vascular, Thoracic and Transplantation Surgery, University of Rostock, Rostock

All Listed Sponsors
collaborator

University Hospital, Ghent

OTHER

collaborator

University of Rostock

OTHER

collaborator

Charite University, Berlin, Germany

OTHER

collaborator

Dr. F. Köhler Chemie GmbH

INDUSTRY

lead

Medical University Innsbruck

OTHER

NCT00737880 - Histidine-Tryptophane-Ketoglutarate (HTK) vs University of Wisconsin (UW) Perfusion in Clinical Pancreas Transplantation | Biotech Hunter | Biotech Hunter